Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4883 studies found for:    "Kidney Diseases"
Show Display Options
Rank Status Study
1 Enrolling by invitation Mechanisms of Diabetic Nephropathy in Ecuador
Conditions: Diabetic Nephropathy;   Diabetes Mellitus;   Kidney Diseases;   Diabetic Kidney Disease;   Chronic Kidney Disease
Intervention:
2 Recruiting Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease
Conditions: Chronic Kidney Disease;   Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Tolvaptan (OPC-41061);   Drug: Placebo
3 Not yet recruiting New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney Disease
Conditions: Autosomal Dominant Polycystic Kidney Disease;   Kidney Disease
Intervention:
4 Completed Effect of N-acetylcysteine (NAC) on Hydrogen Sulfide (H2S) in Chronic Kidney Disease (CKD)
Conditions: Chronic Kidney Disease;   Chronic Kidney Failure;   End Stage Kidney Disease;   End Stage Renal Disease
Intervention: Drug: N-acetylcysteine
5 Completed
Has Results
ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis
Conditions: Chronic Kidney Disease;   End Stage Renal Disease;   Coronary Artery Calcification;   Vascular Calcification;   Calcification;   Cardiovascular Disease;   Chronic Renal Failure;   Hyperparathyroidism;   Kidney Disease;   Nephrology;   Secondary Hyperparathyroidism
Intervention: Drug: cinacalcet
6 Completed
Has Results
Randomized Controlled Trial of Vitamin D3 in Diabetic Kidney Disease
Conditions: Diabetes Mellitus;   Chronic Kidney Disease;   Diabetic Kidney Disease
Interventions: Dietary Supplement: Cholecalciferol;   Dietary Supplement: Placebo
7 Completed A Study in Patients With Diabetic Kidney Disease
Conditions: Diabetic Kidney Disease;   Diabetic Nephropathy;   Diabetic Glomerulosclerosis
Interventions: Drug: LY2382770;   Drug: Placebo
8 Recruiting Pyridorin in Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Diabetic Kidney Disease
Interventions: Drug: Pyridorin;   Drug: Placebo
9 Completed Effect of Integrated CKD Care Program in Early Diabetic Nephropathy in Primary Health Care Setting.
Conditions: Chronic Kidney Disease;   Diabetic Nephropathy
Intervention: Behavioral: Community-based Integrated CKD Care
10 Completed Pilot Study of RNA as a Biomarker for Autosomal Dominant Polycystic Kidney Disease
Conditions: Chronic Kidney Disease;   Polycystic Kidney, Autosomal Dominant
Intervention:
11 Recruiting Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
Conditions: Diabetic Nephropathy;   Diabetes Mellitus;   Diabetic Kidney Disease;   Albuminuria
Intervention:
12 Withdrawn Growth Hormone Secretagogue MK-0677's Effect on Lean Body Mass in Chronic Kidney Disease Stage 4/5 Subjects
Conditions: Chronic Kidney Disease;   Kidney Disease
Interventions: Drug: MK-0677;   Drug: Placebo
13 Completed Olmesartan Medoxomil and Diabetic Nephropathy
Conditions: Type 2 Diabetes Mellitus;   Diabetic Nephropathy;   Proteinuria;   Renal Disease
Interventions: Drug: Olmesartan medoxomil;   Drug: Losartan
14 Unknown  Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration
Conditions: Diabetic Nephropathy;   Chronic Kidney Disease
Intervention: Drug: Mycophenolate Mofetil (MMF) ,phosphodiesterase 5 inhibitors , CARNITINE
15 Recruiting Repository Study of Autosomal Dominant Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention:
16 Completed Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Chronic Kidney Disease;   Diabetes Type 2
Intervention: Drug: N-acetylcysteine
17 Completed 8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Tolvaptan MR;   Drug: Tolvaptan IR;   Drug: Placebo
18 Completed Chronic Kidney Disease Prevention of An-Lo District, Keelung
Conditions: Chronic Kidney Disease;   End Stage Renal Disease;   Death
Intervention: Behavioral: multidisciplinary predialysis education
19 Completed Study to Assess Darbepoetin Alfa in Subjects With Chronic Kidney Disease
Conditions: Kidney Disease;   Chronic Kidney Disease
Intervention: Drug: darbepoetin alfa SF
20 Recruiting Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Polycystic Kidney Disease
Conditions: Chronic Renal Failure;   Polycystic Kidney Disease
Intervention: Biological: Intravenous injection autologous mesenchymal stem cells

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years